Literature DB >> 23193172

The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors.

Eduard Gracia1, Daniel Farré, Antoni Cortés, Carles Ferrer-Costa, Modesto Orozco, Josefa Mallol, Carme Lluís, Enric I Canela, Peter J McCormick, Rafael Franco, Francesca Fanelli, Vicent Casadó.   

Abstract

The enzyme adenosine deaminase (ADA) is a multifunctional protein that can both degrade adenosine and bind extracellularly to adenosine receptors, acting as an allosteric modulator regulating the hormonal effects of adenosine. The molecular regions of ADA responsible for the latter are unknown. In this work, alanine scanning mutagenesis of various ADA amino acid stretches, selected through in silico docking experiments, allowed us to identify regions of the enzyme responsible for modulating both its catalytic activity and its ability to modulate agonist binding to A and A adenosine receptors (AR and AR). The combination of computational and in vitro experiments show that the structural gate to the catalytic site; i.e., the α-1 helix containing residues L58-I72 and the loop containing residues A184-I188 of ADA, were important to maintain both the catalytic efficiency of the enzyme and its action as an allosteric modulator of the adenosine receptors. These data are consistent with a predicted supramolecular assembly, in which ADA bridges AR and CD26 and are in line with the notion that the interaction of ADA with adenosine receptors has an important role in the immunosynapse. We propose that it is the ADA open form, but not the closed one, that is responsible for the functional interaction with A₁R and A₂AR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23193172     DOI: 10.1096/fj.12-212621

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus.

Authors:  Xinrong Tao; Feng Mei; Anurodh Agrawal; Clarence J Peters; Thomas G Ksiazek; Xiaodong Cheng; Chien-Te K Tseng
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

2.  Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.

Authors:  Daniel Farré; Ana Muñoz; Estefanía Moreno; Irene Reyes-Resina; Júlia Canet-Pons; Iria G Dopeso-Reyes; Alberto J Rico; Carme Lluís; Josefa Mallol; Gemma Navarro; Enric I Canela; Antonio Cortés; José L Labandeira-García; Vicent Casadó; José L Lanciego; Rafael Franco
Journal:  Mol Neurobiol       Date:  2014-10-26       Impact factor: 5.590

3.  Enhancement of inosine-mediated A2AR signaling through positive allosteric modulation.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kaviya S Raveendran; Edward P Amento
Journal:  Cell Signal       Date:  2017-11-08       Impact factor: 4.315

Review 4.  [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].

Authors:  Jiang-Biao Xie; Xin-Zhu Lin
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-07-15

5.  Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits.

Authors:  Jan Hendrik Voss; Andhika B Mahardhika; Asuka Inoue; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-03

6.  Catalytically active holo Homo sapiens adenosine deaminase I adopts a closed conformation.

Authors:  Minh Thu Ma; Maria Rain Jennings; John Blazeck; Raquel L Lieberman
Journal:  Acta Crystallogr D Struct Biol       Date:  2022-01-01       Impact factor: 5.699

7.  Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.

Authors:  Matthew R Deshotels; Huijing Xia; Srinivas Sriramula; Eric Lazartigues; Catalin M Filipeanu
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

8.  Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins.

Authors:  Estefanía Moreno; Júlia Canet; Eduard Gracia; Carme Lluís; Josefa Mallol; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

Review 9.  Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.

Authors:  Stephen J Hill; Lauren T May; Barrie Kellam; Jeanette Woolard
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 10.  Adenosine: Direct and Indirect Actions on Gastric Acid Secretion.

Authors:  Rosa M Arin; Adriana Gorostidi; Hiart Navarro-Imaz; Yuri Rueda; Olatz Fresnedo; Begoña Ochoa
Journal:  Front Physiol       Date:  2017-09-22       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.